论文部分内容阅读
目的:对液基细胞学与高危型HPV检测在宫颈癌前病变筛查中的临床应用价值进行评价分析,为今后的临床诊断工作提供可靠的理论依据。方法:抽取在2012年3月-2014年3月间我院收治的临床确诊宫颈疾病患者568例,对其行高危型HPV、液基细胞学以及病理学检查,以病理检查结果为标准对高危型人乳头状瘤病毒(HPV)、液基细胞学检查结果的阳性率、灵敏度、特异性进行评价,并展开对比分析。结果:高危型HPV筛查宫颈上皮内瘤变(CIN)2级及以上病变的阳性率为75.53%,液基细胞学筛查CIN2级及以上病变的阳性率为38.56%,两者差异显著(P<0.05)。结论:高危型HPV检查在宫颈癌前病变筛查中的阳性率、灵敏度和特异性均高于液基细胞学检查,临床价值显著,值得关注并推广。
Objective: To evaluate and evaluate the clinical value of liquid-based cytology and high-risk HPV testing in cervical precancerous lesions screening, and to provide a reliable theoretical basis for future clinical diagnosis. Methods: 568 cases of clinically diagnosed cervical diseases were collected from March 2012 to March 2014 in our hospital. High-risk HPV, liquid-based cytology and pathological examination were performed. According to the results of pathological examination, Human papillomavirus (HPV), liquid-based cytology test results of positive rate, sensitivity and specificity were evaluated and compared. Results: The positive rate of high-risk HPV screening for cervical intraepithelial neoplasia (CIN) grade 2 and above was 75.53%, the positive rate of liquid-based cytology screening for CIN grade 2 and above lesions was 38.56%, the difference was significant P <0.05). Conclusion: The positive rate, sensitivity and specificity of high-risk HPV test in cervical precancerous lesions screening are all higher than those of liquid-based cytology. The clinical value is worthy of attention and popularization.